These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9630811)

  • 21. Transesophageal echocardiographic evaluation of the morphologic and hemodynamic cardiac changes during ventricular fibrillation.
    De Piccoli B; Rigo F; Raviele A; Piccolo E; Maggiolo C; Milanesi A; Simone M
    J Am Soc Echocardiogr; 1996; 9(1):71-8. PubMed ID: 8679239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cerebral hemodynamics of repetitive transcranial magnetic stimulation.
    Pecuch PW; Evers S; Folkerts HW; Michael N; Arolt V
    Eur Arch Psychiatry Clin Neurosci; 2000; 250(6):320-4. PubMed ID: 11153967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency characteristics and associations with the defibrillation threshold of ventricular fibrillation in patients with implantable cardioverter defibrillators.
    Iijima K; Chinushi M; Saitoh O; Hasegawa K; Sonoda K; Yagihara N; Sato A; Izumi D; Watanabe H; Furushima H; Aizawa Y; Minamino T
    Intern Med; 2015; 54(10):1175-82. PubMed ID: 25986253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Reproducibility of the effectiveness of defibrillation for terminating induced ventricular fibrillation using intraoperatively measured defibrillation threshold energy in patients with implanted cardioverter-defibrillator].
    Jung J; Neuzner J; Himmrich E; Vester E; Michel U; Fries R; Pitschner H; Liebrich A; Ganschow U; Heisel A
    Z Kardiol; 1998 Dec; 87(12):971-7. PubMed ID: 10025070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of acute and chronic defibrillation threshold with upper limit of vulnerability determined in normal sinus rhythm.
    Birgersdotter-Green U; Undesser K; Fujimura O; Feld GK; Kass RM; Mandel WJ; Peter CT; Chen PS
    J Interv Card Electrophysiol; 1999 Jul; 3(2):155-61. PubMed ID: 10387143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac output is not affected during intraoperative testing of the automatic implantable cardioverter defibrillator.
    Meyer J; Möllhoff T; Seifert T; Brunn J; Rötker J; Block M; Prien T
    J Cardiovasc Electrophysiol; 1996 Mar; 7(3):211-6. PubMed ID: 8867295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Short-term and long-term outcome of left heart function after cardioverter defibrillator implantation].
    Takeichi K; Kasanuki H; Ohnishi S; Endoh Y; Hosoda S
    J Cardiol; 1996 Nov; 28(5):277-86. PubMed ID: 8953401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brief episodes of ventricular fibrillation do not influence postischemic cerebral perfusion assessed by positron emission tomography.
    Runsiö M; Brodin LA; Eriksson L; Rosenqvist M; Samuelsson S; Stone-Elander S; Owall A; Ingvar M
    Crit Care Med; 1997 Nov; 25(11):1827-30. PubMed ID: 9366765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of ventricular fibrillation duration and site of initiation on the defibrillation threshold during early ventricular fibrillation.
    Strobel JS; Kenknight BH; Rollins DL; Smith WM; Ideker RE
    J Am Coll Cardiol; 1998 Aug; 32(2):521-7. PubMed ID: 9708486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ventricular fibrillation with small amplitude of activation and its implications for implantable cardioverter defibrillator treatment.
    Chinushi M; Kasai H; Tagawa M; Washizuka T; Aizawa Y
    Jpn Heart J; 1999 Jan; 40(1):87-90. PubMed ID: 10370401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ventricular arrhythmias detected after transvenous defibrillator implantation in patients with a clinical history of only ventricular fibrillation. Implications for use of implantable defibrillator.
    Raitt MH; Dolack GL; Kudenchuk PJ; Poole JE; Bardy GH
    Circulation; 1995 Apr; 91(7):1996-2001. PubMed ID: 7895358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Programming of implantable cardioverter-defibrillators on the basis of the upper limit of vulnerability.
    Swerdlow CD; Peter CT; Kass RM; Gang ES; Mandel WJ; Hwang C; Martin DJ; Chen PS
    Circulation; 1997 Mar; 95(6):1497-504. PubMed ID: 9118518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral and systemic hemodynamics changes during upright tilt in chronic fatigue syndrome.
    Razumovsky AY; DeBusk K; Calkins H; Snader S; Lucas KE; Vyas P; Hanley DF; Rowe PC
    J Neuroimaging; 2003 Jan; 13(1):57-67. PubMed ID: 12593133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and electrophysiologic predictors of ventricular tachyarrhythmia recurrence in patients with implantable cardioverter defibrillators.
    Gillis AM; Sheldon RS; Wyse DG; Duff HJ; Cassidy MR; Mitchell LB
    J Cardiovasc Electrophysiol; 2003 May; 14(5):492-8. PubMed ID: 12776866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in cerebral oxygen uptake and cerebral electrical activity during defibrillation threshold testing.
    de Vries JW; Bakker PF; Visser GH; Diephuis JC; van Huffelen AC
    Anesth Analg; 1998 Jul; 87(1):16-20. PubMed ID: 9661538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of ventricular fibrillations with different characteristics in the local electrocardiogram: large and small amplitude of activation, and its implication for implantable cardioverter defibrillator treatment.
    Chinushi M; Washizuka T; Kasai H; Ohhira K; Satoh M; Aizawa Y
    Jpn Circ J; 1999 Dec; 63(12):1007-10. PubMed ID: 10614851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Implantable cardioverter-defibrillator oversensing due to electric shock].
    Jurcević R; Angelkov L; Vukajlović D; Ristić V; Tomović M; Djukanović B
    Srp Arh Celok Lek; 2010; 138(3-4):236-9. PubMed ID: 20499508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral and systemic hemodynamic changes during cognitive and motor activation paradigms.
    Moody M; Panerai RB; Eames PJ; Potter JF
    Am J Physiol Regul Integr Comp Physiol; 2005 Jun; 288(6):R1581-8. PubMed ID: 15677522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical application of the fibrillation number in patients with an implantable cardioverter defibrillator.
    Hwang M; Lee H; Lee YS; Chung S; Choi SH; Shim EB; Pak HN
    Prog Biophys Mol Biol; 2014 Sep; 116(1):33-9. PubMed ID: 25236363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac outflow of endothelin, neuropeptide Y and noradrenaline in relation to hyperaemia in coronary sinus flow following electrical conversion of induced ventricular fibrillation in man.
    Runsiö M; Rosenqvist M; Bergfeldt L; Owall A; Lundberg JM; Franco-Cereceda A
    Eur Heart J; 1995 Dec; 16(12):1925-9. PubMed ID: 8682028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.